Viyash Scientific Q1 FY27 Revenue Up 19.5% to ₹9,464 Million
Viyash Scientific Limited announced its Q1 FY27 financial results, reporting a significant 19.5% increase in revenues to ₹9,464 million. EBITDA grew by 59.2% to ₹2,047 million, and Profit After Tax (PAT) surged by 114.9% to ₹793 million. The company highlighted robust growth driven by integration efforts and strategic acquisitions, such as Bio For Life in Italy, which strengthens its companion animal segment presence in Europe. The Net Debt to EBITDA ratio stood at a healthy 0.1x. The company will host an earnings call on August 12, 2026, to discuss performance and future outlook.
Key Highlights
- Revenue increased by 19.5% to ₹9,464 million in Q1 FY27.
- EBITDA grew substantially by 59.2% to ₹2,047 million.
- PAT saw a remarkable jump of 114.9% to ₹793 million.
- Net Debt/EBITDA ratio improved to 0.1x.
- Acquisition of Bio For Life strengthens European companion animal segment.
Price Impact
More from VIYASH
Viyash Scientific: Promoters CA Harbor & CA Hull Sell 1.17% Stake
Viyash Scientific Approves Financial Results, ESOP Allotment, Vietnam Subsidiary
Viyash Scientific Q1 FY27: consolidated PAT ₹79 Cr, up 115% YoY as margins expand